The effectiveness of peer education on preventive behaviors of HIV and hepatitis B

Not Applicable

• Conditions: Condition 1: HIV. Condition 2: Hepatitis B.; Human immunodeficiency virus [HIV] disease; Acute hepatitis B; B20-B24

• Registration Number: IRCT201612113034N17
• Lead Sponsor: Research Deputy school of Nursing and Midwifery of Iran University of Medical Sciences

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 22 February 2018

Recruitment & Eligibility

• Status: Complete
• Sex: Female
• Target Recruitment: 100

Inclusion Criteria

Age over 18 years;When filling out the questionnaire and participate in the class have the ability to answer and dialogue;Having at least degree of knowledge;substance use at least for 3 months; sexually active;lack of HIV infection.exclusion criteria: do not participate in training class for more than one session;Happening unexpected events

Exclusion Criteria

Not provided

Study & Design

• Study Type: interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Self-esteem. Timepoint: Before intervention, immedately, 4 weeks and 12 weeks after intervention. Method of measurement: Rosenberg Self-esteem Questionnaire.;Perceived Vulnerability to HIV. Timepoint: Before intervention, immedately, 4 weeks and 12 weeks after intervention. Method of measurement: Vulnerability to HIV Questionnaire.;Perceived Vulnerability to Hepatits b. Timepoint: Before intervention, immedately, 4 weeks and 12 weeks after intervention. Method of measurement: Vulnerability to Hepatitis B Questionnaire.;Performance. Timepoint: Before intervention, immedately, 4 weeks and 12 weeks after intervention. Method of measurement: Demographic, Sexual function questionnaire.

Secondary Outcome Measures

Name	Time	Method
Condom use. Timepoint: Before intervention, immedately, 4 weeks and 12 weeks after intervention. Method of measurement: Demographic, Sexual function questionnaire.;HIV test. Timepoint: Before intervention, immedately, 4 weeks and 12 weeks after intervention. Method of measurement: Demographic, Sexual function questionnaire.;HBV TEST. Timepoint: Before intervention, immedately, 4 weeks and 12 weeks after intervention. Method of measurement: Demographic, Sexual function questionnaire.;Type of sex. Timepoint: Before intervention, immedately, 4 weeks and 12 weeks after intervention. Method of measurement: Demographic, Sexual function questionnaire.;Number of partner. Timepoint: Before intervention, immedately, 4 weeks and 12 weeks after intervention. Method of measurement: Demographic, Sexual function questionnaire.;Number of save sex. Timepoint: Before intervention, immedately, 4 weeks and 12 weeks after intervention. Method of measurement: Demographic, Sexual function questionnaire.